45
KAYNAKLAR
1)
Hollick MF. Sunlight and vitamin D for bone health and prevention of autoimmune
diseases, cancer and cardiovascular disease. Am J Clin Nutr 2004; 80 (6suppl): S1678- 88.
2)
Ward LM. Vitamin D deficiency in the 21st century: a persistent problem among
Canadian infants and mothers. CMAJ 2005; 172:769- 70.
3)
Holick MF. The Vitamin D epidemic and its health consequences. J Nutr 2005; 135:
2739- 48.
4)
Heaney RP. Long-latency deficiency disease: insights from calcium and vitamin D. Am
J Clin Nutr 2003; 78: 912- 9.
5)
Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heart
disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 2005; 98:
1024- 7.
6)
Mathieu C, Van Etten E, Decallonne B, Guilietti A, Gyseman C, Bouillon R et al.
Vitamin D and 1,25 dihydroxyvitamin D3 as modulators in immun system. J Steroid Biochem
Mol Biol 2004; 89- 90: 449- 52.
7)
Mathieu C. Adorini L. The coming age of 1,25 dihydroxyvitamin D3 analogs as
immunomodulatory agents. Trends Mol Med 2002; 8: 174- 9.
8)
Đliçin G, Ünal S, Biberoğlu K, Akalın S, Süleymanlar G, Đç Hastalıkları cilt 2 2. Baskı
Ankara: Güneş Kitapevi ISBN 975- 8531- 78- 6. S:2217- 2219.
9)
Lin WY, Wan L, Tsai CH, Chen RH, Lee CC, Tsai FC. Vitamin D receptor gene
polymorphisms are associated with risk of Hashimoto’s thyroiditis in Chinese patients in
Taiwan. J Clin Lab Anal 2006; 20: 109- 12.
10)
Masters PA, Simons RJ. Clinical use of sensitive assays of thyroid stimulating
hormone. J Gen Intern Med 1996; 11: 115- 27.
11)
Jameson JL, Weetman AP. Tiroid bezi hastalıkları. In: Braunwald E, Fauci AS, Kasper
DL, Hauser SL, LongoDL, Jameson JL, editors. Çeviri editörü: Sağlıker Y. Harrison Đç
Hastalıkları Prensipleri (15. Edisyon). Đstanbul: Nobel Matbaacılık; 2004. S.2060-2075
12)
Glass CK, Holloway JM. Regulation of gene expression by the thyroid hormone
receptor. Biochem Biophys Acta 1990; 1032: 157- 76.
13)
Brent GA, Moore DD, Larsen PR. Thyroid hormone regulation of gene expression.
Ann Rev Physiol 1991; 53: 17- 35.
14)
Falk SA. Thyroid disease. New York, Raven Pres 1990; 27- 35.
46
15)
Müller MJ, Seitz HJ. Thyroid hormone action on intermediary metabolism Part I:
respiration, thermogenesis and carbonhydrate metabolism. Klin Wochenschr 1984; 62: 11- 8.
16)
Silvestri E, Schiavo L, Lombardi A. Thyroid hormones as molecular determinant of
termogenesis. Acta Physiol Scand 2005; 184: 265- 83.
17)
Polihar R, Kennedy P, Zieglar M. Plasma norepinephrine kinetics, dopamine, beta
hydroxylase and chromogranine-A5 in hypothyroid patients before and following replacement
therapy. J Clin Endocrinol Metab 1990; 70: 277- 81.
18)
Level GS. Catecholamine sensitivity, thyroid hormone and the heart: A
reevaluation. Am J Med 1971; 50: 413- 20.
19)
Das KC, Mukherjee M, Sarkar TK. Eryhtropoiesis and erythropoietin in hypo- and
hyperthyroidism. J Clin Endocrinol Metab 1975; 40: 211- 20.
20)
Fein HG, Rivlin RS. Anemia in thyroid diseases. Med Clin North Am 1975; 59: 1133-
45.
21)
Poliklinika Vizim, Beograd. Anemia in hypothyroidism. Med Pregl 1999; 52:136- 40.
22)
Pustorino S, Foti M, Calipari G. Thyroid – intestinal motility interactions summary.
Minerva Gastroenterol Dietol 2004; 50: 305- 15.
23)
Kukolja K, Dvorscak D, Beer Z. Intestinal pseudoobstruction in hypothyroidism. Lijec
Vjesn 1990; 112: 165- 7.
24)
Galliford TM, Murphy E, Williams AJ. Effect of thyroid hormone status on bone
metabolism: a primary role for thyroid stimulating hormone or thyroid hormone? Minerva
Endocrinol 2005; 30: 237- 46.
25)
Müler MJ, Seitz HJ. Thyroid hormone action on intermediary metabolism. Part III:
Protein metabolism in hyper- and hyothyroidism. Klin Wochenschr 1984; 62: 97- 102.
26)
Liberopoulos EN, Elisaf MS. Dyslipidemia in patients with thyroid disorders.
Hormones 2002; 1: 218- 223.
27)
Fazio S, Palmieri AE, Lombardi G. Effect of thyroid hormone on the cardiovascular
system. Recent Progress in Hormone Reseach 2004; 59: 31- 50.
28)
Jackson IMD, Hennessey JV, Thyroiditis. In: Becker KL, editors. Principles and
practice of endocrinology and metabolism. Third edition. Lippincott Williams& Wilkins. S.
456-458.
29)
Wang C, Crapo LM. The epidemiology of thyroid disease and implications for
screening. Endocrinol Metab Clin North Am 1997; 26: 189- 218.
30)
Tunbridge WM, Vanderpump MP. Population screening for autoimmune thyroid
disease. Endocrinol Metab Clin North Am 2000; 29: 239- 253.
47
31)
Weetman PA, Section B: Causes of hypothyroidism, chronic autoimmune thyroiditis,
In: Lewis E.B, Robert D.U,eds, Werner’s & Ingbar’s, The Thyroid, Philadelphia, Baltimore,
New York. Lippincott Williams& Wilkins, 8.edition 2000; S. 731- 732.
32)
Drexhage H, Bottazzo G, Bitensky L. Thyroid growth- blocking antibodies in primary
myxedema. Nature 1981; 289: 594.
33)
Chistiakov DA. Immunogenetics of Hashimoto’s thyroiditis. J Autoimmune Dis 2005;
2: 1.
34)
Devendra D, Eisenbarth GS. Immunological endocrine disorders. J Allergy Clin
Immunol 2003; 111:624- 36.
35)
Volpe R. Autoimmune thyoiditis. In: Braverman LE, Utiger RD, editors. Werner and
Ingbar’s the thyroid, 5th ed. Philadelphia: JB Lippincott, 1991: S. 921.
36)
Boukis MA, Koutras DA, Souvatzoglou A. Thyroid hormone and immunologic studies
in endemic goitre. J Clin Endocrinol Metab 1983; 57: 859- 62.
37)
Harach HR, Eslacante DA, Onativia A. Thyroid carcinoma and thyroiditis in an
endemic goitre region before and after iodine prophylaxis. Acta Endocrinol 1985; 108: 55- 60.
38)
Allen EM, Apel MC, Braverman LE. The effect of iodide ingestion on the development
of spontaneous lympholytic thyroiditis in the diabetesprone BB/W rat. Endocrinology 1986;
118:1977- 81.
39)
Rasooly L, Burek CL, Rose NR. Iodine- induced autoimmune thyroiditis in NOD-H-
2h4 mice. Clin Immunol Immunopathol 1996; 81: 287- 92.
40)
Ruwhof C, Draxhage HA. Iodine and thyroid autoimmune disease in animal models.
Thyroid 2001; 11: 427- 36.
41)
Champion BR, Page KR, Parish N. Identification of a thyroxine- containing self-
epitope of thyroglobulin which triggers thyroid autoreactive T cell. J Exp Med 1991; 174: 363-
70.
42)
Rasooly L, Rose NR, Saboori AM. Iodine is essential for human T cell recognition of
human thyroglobulin. Autoimmunity 1998; 27: 213-19.
43)
Ebner SA, Lueprasitsakul W, Alex S. Iodine content of rat thyroglobuline affects its
autogenicity in inducing lympholytic thyroiditis in the BB/Wor rat. Autoimmunity 1992; 13:
209- 214.
44)
Bretz JD, Baker JR Jr. Apoptosis and autoimmune thyroid disease: following a trail to
thyroid destruction? Clin Endocrinol 2001; 55: 1- 11.
45)
Rasmussen AK. Cytokine actions on the thyroid gland. Dan Med Bull 2000; 47: 94-
114.
Dostları ilə paylaş: |